Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Oncology
  4. Effect of Minimally Invasive Spine Stabilization in Metastatic Spinal Tumors

Effect of Minimally Invasive Spine Stabilization in Metastatic Spinal Tumors

Medicina, 2022 · DOI: https://doi.org/10.3390/medicina58030358 · Published: March 1, 2022

OncologySurgery

Simple Explanation

Minimally invasive spine stabilization (MISt) is a surgical technique used for metastatic spinal tumors. It temporarily stabilizes the spine, reduces pain, and prevents fractures. MISt is less invasive than conventional surgery. It leads to reduced bleeding and earlier recovery. MISt allows for early postoperative ambulation and early discharge. This is a very helpful benefit for patients with metastatic spinal tumors because their life expectancy is limited.

Study Duration
December 2013 to October 2020
Participants
51 patients with metastatic spinal tumors
Evidence Level
Not specified

Key Findings

  • 1
    MISt can benefit patients who are ineligible for conventional, highly invasive surgery.
  • 2
    Patients with breast, prostate, renal, and thyroid cancers had a good prognosis, whereas those with gastrointestinal and head and neck cancers had a poor prognosis.
  • 3
    The median duration of patient survival was about 22.0 months.

Research Summary

This study evaluated the effect of minimally invasive spine stabilization (MISt) in 51 patients with metastatic spinal tumors. MISt is a minimally invasive fixation procedure that temporarily stabilizes the spine, thereby reducing pain, preventing pathological fractures, and improving activities of daily living at an early stage. The results showed that MISt can benefit patients who are ineligible for conventional, highly invasive surgery and is also suitable because cancer treatment is increasingly performed on an outpatient basis. Furthermore, choosing the right surgery for the right patient at the right time can significantly affect life expectancy.

Practical Implications

Improved Quality of Life

MISt can improve the quality of life for patients with metastatic spinal tumors by reducing pain and improving mobility.

Outpatient Treatment

MISt is suitable for patients receiving outpatient cancer treatment, allowing for early discharge and transition to adjuvant therapies.

Personalized Treatment

Choosing the right surgery for the right patient at the right time is crucial for maximizing life expectancy.

Study Limitations

  • 1
    Small number of cases in the surgery group.
  • 2
    Lack of analysis of each type of carcinoma.
  • 3
    Lack of a control in this study.

Your Feedback

Was this summary helpful?

Back to Oncology